Effects of long-term treatment with verapamil on left ventricular function and myocardial blood flow in patients with dilated cardiomyopathy without overt heart failure

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 6, 2000, Pages 744-750

  Neglia, Danilo ^a,b   Sambuceti, Gianmario ^a,b   Giorgetti, Assuero ^a,b   Bartoli, Monica ^a,b   Salvadori, Piero ^a,b   Sorace, Oreste ^a,b   Puccini, Giacomo ^a,b   L'Abbate, Antonio ^a,b   Parodi, Oberdan ^a,b,c  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b CNR   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Coronary microcirculation; Dilated cardiomyopathy; Enalapril; Myocardial blood flow; Ventricular function; Verapamil

Indexed keywords

ENALAPRIL; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033653154     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200012000-00009     Document Type: Article

References (14)

1. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy
2. Coronary flow reserve in patients with dilated cardiomyopathy
3. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy
4. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure
5. Prognostic role of coronary microvascular dysfunction in mild dilated cardiomyopathy
6. Effects of verapamil on coronary hemodynamic function and vasomotility relative to its mechanism of antianginal action
7. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis
8. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension
9. Behavior of right and left ventricles during episodes of variant angina in relation to the site of coronary vasospasm
10. Assignment of patients into the classification of cardiomyopathies
11. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
12. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction
13. Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: A review of clinical investigations
14. Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction